NO142301B - PROCEDURE FOR THE PREPARATION OF HETEROCYCLIC BENZAMIDE COMPOUNDS - Google Patents
PROCEDURE FOR THE PREPARATION OF HETEROCYCLIC BENZAMIDE COMPOUNDS Download PDFInfo
- Publication number
- NO142301B NO142301B NO259273A NO259273A NO142301B NO 142301 B NO142301 B NO 142301B NO 259273 A NO259273 A NO 259273A NO 259273 A NO259273 A NO 259273A NO 142301 B NO142301 B NO 142301B
- Authority
- NO
- Norway
- Prior art keywords
- sulfamoyl
- compound
- lower alkyl
- formula
- chlorosulfonyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 40
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical class NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title claims description 20
- 238000002360 preparation method Methods 0.000 title claims description 13
- -1 heterocyclic benzamide compound Chemical class 0.000 claims description 41
- 150000001875 compounds Chemical class 0.000 claims description 33
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 7
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 claims description 5
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 claims description 5
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims description 5
- 150000003335 secondary amines Chemical class 0.000 claims description 5
- 238000007098 aminolysis reaction Methods 0.000 claims description 4
- 238000005915 ammonolysis reaction Methods 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 239000005711 Benzoic acid Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- ILUJQPXNXACGAN-UHFFFAOYSA-N O-methylsalicylic acid Chemical compound COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 description 6
- 229940054066 benzamide antipsychotics Drugs 0.000 description 6
- BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 description 5
- 235000010233 benzoic acid Nutrition 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 229960004940 sulpiride Drugs 0.000 description 5
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- 150000003141 primary amines Chemical class 0.000 description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000009435 amidation Effects 0.000 description 3
- 238000007112 amidation reaction Methods 0.000 description 3
- 239000000908 ammonium hydroxide Substances 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- BGRJTUBHPOOWDU-UHFFFAOYSA-N sulpiride Chemical group CCN1CCCC1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- LODHFNUFVRVKTH-ZHACJKMWSA-N 2-hydroxy-n'-[(e)-3-phenylprop-2-enoyl]benzohydrazide Chemical compound OC1=CC=CC=C1C(=O)NNC(=O)\C=C\C1=CC=CC=C1 LODHFNUFVRVKTH-ZHACJKMWSA-N 0.000 description 2
- SQAILWDRVDGLGY-UHFFFAOYSA-N 2-methoxy-5-sulfamoylbenzoic acid Chemical compound COC1=CC=C(S(N)(=O)=O)C=C1C(O)=O SQAILWDRVDGLGY-UHFFFAOYSA-N 0.000 description 2
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 229940051881 anilide analgesics and antipyretics Drugs 0.000 description 2
- 150000003931 anilides Chemical class 0.000 description 2
- KXADPELPQCWDHL-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1.COC1=CC=CC=C1 KXADPELPQCWDHL-UHFFFAOYSA-N 0.000 description 2
- 239000002111 antiemetic agent Substances 0.000 description 2
- 229940125683 antiemetic agent Drugs 0.000 description 2
- 150000003936 benzamides Chemical class 0.000 description 2
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- UHCGCOWDMZJDOC-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide Chemical compound CCN1CCCC1CNC(=O)C1=CC=CC=C1OC UHCGCOWDMZJDOC-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000005049 silicon tetrachloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- UNRBEYYLYRXYCG-UHFFFAOYSA-N (1-ethylpyrrolidin-2-yl)methanamine Chemical compound CCN1CCCC1CN UNRBEYYLYRXYCG-UHFFFAOYSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- SEYURSMOEWBZSA-UHFFFAOYSA-N 2-(1-ethylpyrrolidin-2-yl)ethanamine Chemical compound CCN1CCCC1CCN SEYURSMOEWBZSA-UHFFFAOYSA-N 0.000 description 1
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 1
- VNMNRMBWSGJGAT-UHFFFAOYSA-N 2-(dichloromethyl)phenol Chemical compound OC1=CC=CC=C1C(Cl)Cl VNMNRMBWSGJGAT-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- NGZDOBOMNMAJSK-UHFFFAOYSA-N Cl.C(C)N1C(CCC1)CNC(C1=C(C=CC=C1)OC)=O Chemical compound Cl.C(C)N1C(CCC1)CNC(C1=C(C=CC=C1)OC)=O NGZDOBOMNMAJSK-UHFFFAOYSA-N 0.000 description 1
- 238000005666 Myers alkylation reaction Methods 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000005224 alkoxybenzenes Chemical class 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N methyl phenyl ether Natural products COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- YIONPZZGQSPBEL-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxybenzamide Chemical compound CCN1CCCC1CNC(=O)C1=CC=CC=C1O YIONPZZGQSPBEL-UHFFFAOYSA-N 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Foreliggende oppfinnelse angår generelt fremgangsmåter ved frem stilling av visse kjente biologisk aktive heterocycliske benzamidforbindelser ved hvilken en ny gruppe forbindelser anvendes. Mere spesielt angår oppfinnelsen fremgangsmåter ved fremstilling av visse kjente biologisk aktive heterocycliske benzamidforbindelser hvori en ny gruppe forbindelser anvendes. Mere spesielt angår oppfinnelsen fremgangsmåter ved fremstilling av heterocycliske benzamidforbindelser med den generelle formelt hvor X er sulfamoyl, N-laverealkyl-sulfamoyl eller N,N-di-(laverealkyl)-sulfamoyl, R er laverealkyl, R^ er laverealkyl, n er O, 1 eller 2, og m er 1 eller 2. Disse fremgangsmåter er nye og fordelaktige, idet de foregår over en ny gruppe forbindelser som er heterocycliske benzamidforbindelser med den generelle formel: The present invention generally relates to methods for the preparation of certain known biologically active heterocyclic benzamide compounds in which a new group of compounds is used. More particularly, the invention relates to methods for the production of certain known biologically active heterocyclic benzamide compounds in which a new group of compounds is used. More particularly, the invention relates to methods for the preparation of heterocyclic benzamide compounds with the general formula where X is sulfamoyl, N-lower alkyl-sulfamoyl or N,N-di-(lower alkyl)-sulfamoyl, R is lower alkyl, R^ is lower alkyl, n is O, 1 or 2, and m is 1 or 2. These methods are new and advantageous, in that they are carried out over a new group of compounds which are heterocyclic benzamide compounds of the general formula:
hvor R, R^, n og m er som ovenfor angitt. Representative forbindelser av formel II er i seg selv biologisk aktive, og alle kan lett overføres ved bekvemme metoder til heterocycliske benzamider med formel I. where R, R^, n and m are as indicated above. Representative compounds of formula II are themselves biologically active, and all can be easily converted by convenient methods to heterocyclic benzamides of formula I.
Heterocycliske benzamider med formel I er generelt beskrevet i kanadisk patent nr. 801.043- I det nevnte patentskrift er slike heterocycliske benzamidforbindelser beskrevet som værende biologisk aktive og er angitt å ha anvendbarhet som antiemetika og ved behandling av mentale lidelser. Antagelig den best kjente av slike forbindelser på det nuværende tidspunkt er l-ethyl-2-(2-methoxy-5-sulf-amoylbenzamidomethyl)-pyrrolidin, alternativt N-[(1-ethyl-2-pyrro-lidinyl)-methyl]-5-sulfamoyl-o-anisamid, vanligvis betegnet, som sulpirid, som anvendes i kjemoterapien som et antidepressant,"anti-pyretisk og antiemetisk middel, og mere generelt som en regulator av fordøyelsessystemet. Heterocyclic benzamides of formula I are generally described in Canadian patent no. 801,043- In the said patent, such heterocyclic benzamide compounds are described as being biologically active and are indicated to have applicability as antiemetics and in the treatment of mental disorders. Probably the best known of such compounds at the present time is 1-ethyl-2-(2-methoxy-5-sulf-amoylbenzamidomethyl)-pyrrolidine, alternatively N-[(1-ethyl-2-pyrro-lidinyl)-methyl] -5-sulfamoyl-o-anisamide, usually designated, as sulpiride, which is used in chemotherapy as an antidepressant, anti-pyretic and anti-emetic agent, and more generally as a regulator of the digestive system.
Det ovennevnte patentskrift angir fremstillingen av de heterocycliske benzamidforbindelser med formel I ved å omsette en forut-fremstilt 2-alkoxy-5-substituert benzoesyre, i form av et reaktivt derivat, f.eks. syrekloridet, med det passende forutfremstilte heterocycliske amin. Denne tidligere fremgangsmåte er illustrert nedenfor: hvor R, X, n og n cx «om ovenfor angitt. For å ta et eksempel, ved fremstilling av l-ethyl-2-(2-methoxy-5-sulfaraoylbenzamidomethyl)-pyrrolidin, dvs. sulpirid, i henhold til teknikkens stand omtalt - ovenfor, omsettes l-ethyl-2-aminomethylpyrrolidin oed 2-methoxy-5~ sulfaooyl-benzoylklorid. The above-mentioned patent specifies the preparation of the heterocyclic benzamide compounds of formula I by reacting a previously prepared 2-alkoxy-5-substituted benzoic acid, in the form of a reactive derivative, e.g. the acid chloride, with the appropriate preformed heterocyclic amine. This prior process is illustrated below: where R, X, n and n cx «if indicated above. To take an example, in the preparation of l-ethyl-2-(2-methoxy-5-sulfaraoylbenzamidomethyl)-pyrrolidine, i.e. sulpiride, according to the state of the art discussed - above, l-ethyl-2-aminomethylpyrrolidine oed 2 is reacted -methoxy-5-sulfaooyl-benzoyl chloride.
Fremstillingen av de 2,5-disubstituerte benzoesyreforbindelser som f.eks. 2-methoxy-5-sulfamoyl-benzoesyre, er beskrevet i franske patentskrifter 1.524-388 og 1.525.352. I det tidligere nevnte patent skrift fremstilles forbindelsene fra et alkoxybenzen som methoxyben-zen (anisol) ved en seks-trinns reaksjonsrekke innbefattende: klorsulfonering for å få et p-alkoxybenzen-sulfonylklorid; nitrering for å få 3-Tiitro-4-alkoxybenzen-sulfonylklorid; aminering for å få 2-nitro-4-sulfamoyl-alkoxybenzen; reduksjon av nitrogruppen for å få det tilsvarende 2-amino-4_sulfamoyl-alkoxybenzen; og overføring av aminogruppen til en carboxylsyregruppe med dannelse av den ønskede 2-alkoxy-5-sulf amoyl-benzoesyre ved en konvensjonell to-trinns i>and-meyer-reaksjon som innbefatter først overføring av aminogruppen til en cyanogruppe fulgt av hydrolyse av cyanogruppen. Totalutbyttet av 2-alkoxy-5-sulfamoyl-benzoesyren som vist i det forannevnte patentskrift, er av størrelsesorden 14%. The preparation of the 2,5-disubstituted benzoic acid compounds such as e.g. 2-methoxy-5-sulfamoyl-benzoic acid, is described in French patents 1,524-388 and 1,525,352. In the previously mentioned patent document, the compounds are prepared from an alkoxybenzene such as methoxybenzene (anisole) by a six-step reaction sequence including: chlorosulfonation to obtain a p-alkoxybenzenesulfonyl chloride; nitration to give 3-Titro-4-Alkoxybenzenesulfonyl chloride; amination to give 2-nitro-4-sulfamoyl-alkoxybenzene; reduction of the nitro group to give the corresponding 2-amino-4-sulfamoyl-alkoxybenzene; and transfer of the amino group to a carboxylic acid group to form the desired 2-alkoxy-5-sulfamoyl-benzoic acid by a conventional two-step i>and-meyer reaction involving first transfer of the amino group to a cyano group followed by hydrolysis of the cyano group. The total yield of the 2-alkoxy-5-sulfamoyl-benzoic acid, as shown in the aforementioned patent, is of the order of 14%.
I henhold til fransk patentskrift 1. 525. 352 fremstilles den ønskede 2-alkoxy-5-sulfamoyl-benzoesyre fra en o-nitrofenol i en seks-trinns reaksjonsrekke som innbefatter: alkylering for å få den tilsvarende o-nitro-alkoxyfenol; klorsulfonering for å få 3-nitro-4-alkoxybenzen-sulfonylklorid; aminering for å få 2-nitro-4-sulfamoyl-alkoxybenzen; reduksjon av nitrogruppen for å få det tilsvarende 2-amino-4-sulfamoyl-alkoxybenzen; og overføring av aminogruppen til en carboxylsyregruppe med dannelse av den ønskede 2-alkoxy-5_sulfamoyl-benzoesyre igjen ved en konvensjonell to-trinns Sandmeyer-reaksjon som innbefatter først overføring av aminogruppen til en cyanogruppe fulgt av hydrolyse av cyanogruppen. Intet utbytte er angitt i patentskriftet.for den annentrinns klorsulfonering, men selv under antagelse av et 100% utbytte i dette trinn, ville totalutbyttet bare være av størrelsesorden 10%. According to French patent document 1.525.352, the desired 2-Alkoxy-5-sulfamoyl-benzoic acid is prepared from an o-nitrophenol in a six-step reaction sequence which includes: alkylation to obtain the corresponding o-nitro-Alkoxyphenol; chlorosulfonation to give 3-nitro-4-alkoxybenzenesulfonyl chloride; amination to give 2-nitro-4-sulfamoyl-alkoxybenzene; reduction of the nitro group to give the corresponding 2-amino-4-sulfamoyl-alkoxybenzene; and transfer of the amino group to a carboxylic acid group to form the desired 2-alkoxy-5-sulfamoyl-benzoic acid again by a conventional two-step Sandmeyer reaction involving first transfer of the amino group to a cyano group followed by hydrolysis of the cyano group. No yield is stated in the patent for the second-stage chlorosulfonation, but even assuming a 100% yield in this step, the total yield would only be of the order of 10%.
I begge tilfelle må den således erholdte 2-alkoxy-5-sulfamoyl-benzoesyre (som beskrevet i det førnevnte kanadiske patentskrift og det franske B.S.M.) overføres til syrekloridet (eller annet reaktivt derivat) som dereftef omsettes med den forutdannede heterocycliske forbindelse for å få den ønskede heterocycliske benzamidforbindelse. Skjønt ingen utbyttedata er tilstede i det kanadiske eller franske patent, følger det av det foregående at totalutbyttet av den heterocycliske benzamidforbindelse ved de to preparative ruter kan ikke være mere enn 14% og sannsynligvis under 10%. In both cases the 2-Alkoxy-5-sulfamoyl-benzoic acid thus obtained (as described in the aforementioned Canadian patent and the French B.S.M.) must be transferred to the acid chloride (or other reactive derivative) which is then reacted with the preformed heterocyclic compound to obtain the desired heterocyclic benzamide compound. Although no yield data is present in the Canadian or French patent, it follows from the foregoing that the total yield of the heterocyclic benzamide compound by the two preparative routes cannot be more than 14% and probably less than 10%.
Oppsummert innbefatter disse tidligere kjente fremgangsmåter for fremstilling av de heterocycliske benzamidforbindelser med formel I, som vesentlige trekk, dannelsen av den passende substituerte benzoesyre, f.eks. 2-alkoxy-5-sulfamoyl-benzoesyre, dennes overføring til et reaktivt derivat, bekvemt syrekloridet, og kondensasjon av det reaktive benzoesyrederivat inneholdende alle de passende substi-tuenter på benzenringen, med det passende heterocycliske amin. I alt er det åtte individuelle ireaks jonst rinn i disse tidligere kjente fremgangsmåter. In summary, these previously known methods for the preparation of the heterocyclic benzamide compounds of formula I include, as essential features, the formation of the suitably substituted benzoic acid, e.g. 2-Alkoxy-5-sulfamoyl-benzoic acid, its transfer to a reactive derivative, conveniently the acid chloride, and condensation of the reactive benzoic acid derivative containing all the appropriate substituents on the benzene ring, with the appropriate heterocyclic amine. In total, there are eight individual reactions in these previously known methods.
Det har nu vist seg at de kjente heterocycliske benzamidforbindelser med formel I kan fremstilles ved meget fordelaktige fremgangsmåter som innbefatter tilsammen bare 3 eller 4 individuelle reaksjonstrinn sammenlignet med de åtte-trinns fremgangsmåter ifølge teknikkens stand, og som fører til gode utbytter av de ønskede forbindelser , særlig l-ethyl-2-(2-methoxy-5-sulfamoyl-benzamidomethyl)-pyrrolidin (sulpirid). It has now been shown that the known heterocyclic benzamide compounds of formula I can be prepared by very advantageous methods which include a total of only 3 or 4 individual reaction steps compared to the eight-step methods according to the state of the art, and which lead to good yields of the desired compounds. especially 1-ethyl-2-(2-methoxy-5-sulfamoyl-benzamidomethyl)-pyrrolidine (sulpiride).
I henhold til foreliggende oppfinnelse, According to the present invention,
fremskaffes der en fremgangsmåte ved fremstilling av en heterocyclisk benzamidforbindelse med den generelle formel (I) som omfatter klor-sulf onering av en forbindelse med den generelle formel: there is provided a method for the preparation of a heterocyclic benzamide compound of the general formula (I) which comprises chlorosulfonation of a compound of the general formula:
hvor R, R^, m og n er som ovenfor angitt, til den tilsvarende 5-klorsulfonylforbindelse med den generelle formel: where R, R^, m and n are as indicated above, to the corresponding 5-chlorosulfonyl compound of the general formula:
hvor R, R^, n og m er som ovenfor angitt,' derefter overføres 5-klorsulfonylforbindelsen med formel Ilb, som kan isoleres eller ikke efter valg, til en forbindelse med formel I ved ammonolyse med ammoniakk eller aminolyse med et primært amin eller et sekundært amin for å få hhv. 5-sulfamoyl-, 5-N-laverealkyl-sulfamoyl- eller 5-N,N-di-(laverealkyl)-sulfamoylforbindelsen. Den således erholdte forbindelse med formel I kan derefter overføres til et N-oxyd eller et syreaddisjonssalt eller kvartært ammoniumsalt. where R, R^, n and m are as above, then the 5-chlorosulfonyl compound of formula IIb, which may or may not be isolated as desired, is transferred to a compound of formula I by ammonolysis with ammonia or aminolysis with a primary amine or a secondary amine to get resp. The 5-sulfamoyl, 5-N-lower alkyl sulfamoyl or 5-N,N-di-(lower alkyl) sulfamoyl compound. The thus obtained compound of formula I can then be transferred to an N-oxide or an acid addition salt or quaternary ammonium salt.
De heterocycliske benzamidforbindelser med formel II er nye forbindelser som er mere fullstendig beskrevet, sammen med fremgangsmåter for fremstilling av dem, i norsk patent (ansøkning 2591/73). The heterocyclic benzamide compounds of formula II are new compounds which are more fully described, together with methods for their preparation, in a Norwegian patent (application 2591/73).
Eksempelvis kan de 5-usubstituerte forbindelser med formel Ila bekvemt fremstilles ved amidering av en benzoesyreforbindelse med den generelle formel: hvor R er som ovenfor beskrevet, ved å omsette benzoesyreforbindelsen eller et reaktivt derivat derav, med et heterocyclisk amin med den generelle formel: For example, the 5-unsubstituted compounds of formula IIa can be conveniently prepared by amidation of a benzoic acid compound of the general formula: where R is as described above, by reacting the benzoic acid compound or a reactive derivative thereof, with a heterocyclic amine of the general formula:
hvor , m og n er som ovenfor angitt, i nærvær av et kondenserings-middel som siliciumtetraklorid eller N,N-dicyclohexylcarbodiimid. where , m and n are as above, in the presence of a condensing agent such as silicon tetrachloride or N,N-dicyclohexylcarbodiimide.
De tilsvarende 5-klorsulfonylforbindelser med formel Ilb kan fåes ved klorsulfonering av de 5-usubstituerte forbindelser. The corresponding 5-chlorosulfonyl compounds of formula IIb can be obtained by chlorosulfonation of the 5-unsubstituted compounds.
En total A total
fremgangsmåte for fremstilling av de ønskede heterocycliske benzamider med den generelle formel I, kan således omfatte: A. amidering av en 2-alkoxy-benzoesyreforbindelsé med formel III process for the preparation of the desired heterocyclic benzamides with the general formula I, can thus include: A. amidation of a 2-alkoxy-benzoic acid compound with formula III
ved omsetning med et heterocyclisk amin med formel IV for å få en heterocyclisk benzamidforbindelse med formel Ila, by reaction with a heterocyclic amine of formula IV to obtain a heterocyclic benzamide compound of formula IIa,
B. klorsulfonering av den heterocycliske benzamidforbindelse for å B. chlorosulfonation of the heterocyclic benzamide compound to
få den tilsvarende 5-klorsulfonylforbindelse med formel Ilb, og C. ammonolyse eller aminolyse av 5-klorsulfonylforbindelsen ved omsetning med ammoniakk eller et primært amin eller sekundært amin for å få hhv. den tilsvarende 5-sulfamoyl-, N-laverealkyl-sulfamoyl- eller N,N-di-(laverealkyl)-sulfamoylforbindelse med formel I. obtain the corresponding 5-chlorosulfonyl compound of formula Ilb, and C. ammonolysis or aminolysis of the 5-chlorosulfonyl compound by reaction with ammonia or a primary amine or secondary amine to obtain respectively the corresponding 5-sulfamoyl-, N-lower alkyl-sulfamoyl- or N,N-di-(lower alkyl)-sulfamoyl compound of formula I.
Ved en alternativ fremgangsmåte for fremstilling av de 5-usubstituerte forbindelser med formel Ila, omsettes en benzoesyreforbindelse med den generelle formel: In an alternative method for preparing the 5-unsubstituted compounds of formula IIa, a benzoic acid compound of the general formula is reacted:
i form av den frie syre eller et reaktivt derivat derav, med et heterocyclisk amin med den generelle formel: hvor R^, m og n er som ovenfor angitt, for å få en heterocyclisk benzamidforbindelse med den generelle formel: in the form of the free acid or a reactive derivative thereof, with a heterocyclic amine of the general formula: where R^, m and n are as indicated above, to obtain a heterocyclic benzamide compound of the general formula:
hvor R^, m og n er som ovenfor angitt, som så alkyleres i 2-still-ingen for å få den tilsvarende 2-laverealkoxyforbindelse med formel Ila. where R 1 , m and n are as indicated above, which is then alkylated in the 2-position to obtain the corresponding 2-lower alkoxy compound of formula IIa.
En annen total fremgangsmåte for fremstilling av de ønskede heterocycliske benzamider med formel I, innbefatter: A. amidering av 2-hydroxy-benzoesyre med formel III<*> ved omsetning av den frie syre eller et reaktivt derivat derav, med et heterocyclisk amin med formel IV for å få en heterocyclisk benzamidforbindelse med formel Ila', B. alkylering av forbindelsen med formel Ila' med overføring av hydroxygruppen til en laverealkoxygruppe for å få en forbindels* med formel Ila, C. klorsulfonering av den heterocycliske benzamidforbindelse med formel Ila for å få den tilsvarende 5-klorsulfonylforbindelse med formel Ilb, og D. ammonolyse eller aminolyse av 5-klorsulfonylforbindelsen ved omsetning med ammoniakk eller et primært amin eller et sekundærl amin for å få hhv. den tilsvarende 5-sulfamoyl-, N-laverealkyl-sulfamoyl- eller N,N-di-(laverealkyl)-sulfamoylforbindelse med formel I. Another overall process for the preparation of the desired heterocyclic benzamides of formula I includes: A. amidation of 2-hydroxy-benzoic acid of formula III<*> by reaction of the free acid or a reactive derivative thereof, with a heterocyclic amine of formula IV to obtain a heterocyclic benzamide compound of formula Ila', B. alkylation of the compound of formula Ila' with transfer of the hydroxy group to a lower alkoxy group to obtain a compound* of formula Ila, C. chlorosulfonation of the heterocyclic benzamide compound of formula Ila to obtain the corresponding 5-chlorosulfonyl compound of formula IIb, and D. ammonolysis or aminolysis of the 5-chlorosulfonyl compound by reaction with ammonia or a primary amine or a secondary amine to obtain resp. the corresponding 5-sulfamoyl-, N-lower alkyl-sulfamoyl- or N,N-di-(lower alkyl)-sulfamoyl compound of formula I.
Den 5-usubstituerte heterocycliske benzamid-utgangsforbindelse med formel Ila for klorsulfoneringsreaksjonen kan anvendes i form av den frie base eller et salt, f.eks. et syreaddisjonssalt med en miner-alsyre som saltsyre. Bekvemt anvendes den i form av et syreaddisjonssalt. The 5-unsubstituted heterocyclic benzamide starting compound of formula IIa for the chlorosulfonation reaction can be used in the form of the free base or a salt, e.g. an acid addition salt with a mineral acid such as hydrochloric acid. It is conveniently used in the form of an acid addition salt.
Klorsulfoneringsreaksjonen kan utføres ved en hvilken som helst vanlig metode. I en konvensjonell metode bringes et overskudd av klorsulfonsyre i kontakt med det 5-usubstituerte heterocycliske benzamid med formel Ila, og blandingen oppvarmes, fortrinnsvis ved en temperatur i området 50 - 150°C, inntil reaksjonen er i det vesentlige fullst endig. The chlorosulfonation reaction can be carried out by any conventional method. In a conventional method, an excess of chlorosulfonic acid is brought into contact with the 5-unsubstituted heterocyclic benzamide of formula IIa, and the mixture is heated, preferably at a temperature in the range of 50-150°C, until the reaction is substantially complete.
Ved en fordelaktig metode isoleres den således dannede 5-klorsulfonylforbindelse ikke, men overføres istedet direkte til den tilsvarende 5-sulfamoyl-, N-laverealkyl-sulfamoyl- eller N,N-di-(laverealkyl)-sulf amoylforbindelse. 5-sulfamoylforbindelsen f remstilles bekvemt ved å omsette 5-klorsulfonylforbindeIsen med konsentrert ammoniakk, mens 5-N-laverealkyl-sulfamoyl- og 5-N,N-di-(laverealkyl)-sulfamoylforbindelsene overføres bekvemt ved omsetning med det passende substituerte primære eller sekundære amin. In an advantageous method, the 5-chlorosulfonyl compound thus formed is not isolated, but is instead transferred directly to the corresponding 5-sulfamoyl, N-lower alkyl sulfamoyl or N,N-di-(lower alkyl) sulfamoyl compound. The 5-sulfamoyl compound is conveniently prepared by reacting the 5-chlorosulfonyl compound with concentrated ammonia, while the 5-N-lower alkyl sulfamoyl and 5-N,N-di-(lower alkyl) sulfamoyl compounds are conveniently transferred by reaction with the appropriately substituted primary or secondary amine.
Som illustrasjon er en fordelaktig tre-trinns metode for fremstilling av en representativ heterocyclisk benzamidforbindelse, By way of illustration, an advantageous three-step method for the preparation of a representative heterocyclic benzamide compound is,
nemlig sulpirid, i henhold til foreliggende oppfinnelse vist i prosesskjema II, idet metoden innbefatter 4 trinn, og derfor er kommersielt mindre tiltrekkende enn de andre illustrerte metoder. namely sulpiride, according to the present invention shown in process scheme II, as the method includes 4 steps, and is therefore commercially less attractive than the other illustrated methods.
Til sammenligning illustrerer prosesskjema III metoden for fremstill- For comparison, process diagram III illustrates the method for producing
ing av den samme forbindelse som beskrevet i fransk patentskrift 1-524.388» og (i forbindelse med de to siste trinn) i fransk B.S.M. nr. 59l6. ing of the same compound as described in French patent document 1-524,388" and (in connection with the last two steps) in French B.S.M. No. 59l6.
Litteraturen som en helhet er generelt forvirrende og tildels motsigende med hensyn til hvilke produkter som kan ventes ved en klorsulfoneringsreaksjon. Det er med andre ord ingen klar lære i litteraturen med hensyn til hvilke produkter som i det hele tatt kan ventes. Videre er det hverken beskrevet eller foreslått eller endog antydet at en benzamid-forbindelse kan klorsulfoneres med de meget gode resultater som oppnås ved fremgangsmåten ifølge oppfinnelsen. Elektronstrukturen hos de anilider som det er kjent å klorsulfonere, er vesentlig for-skjellig fra strukturen hos benzamidene, særlig når man tar i betraktning den mulige resonansstruktur hos anilider og benzamider. The literature as a whole is generally confusing and partly contradictory with regard to which products can be expected from a chlorosulfonation reaction. In other words, there is no clear teaching in the literature with regard to which products can be expected at all. Furthermore, it has neither been described nor proposed nor even suggested that a benzamide compound can be chlorosulfonated with the very good results obtained by the method according to the invention. The electronic structure of the anilides which are known to be chlorosulfonated is significantly different from the structure of the benzamides, especially when one takes into account the possible resonance structure of anilides and benzamides.
Det vil være klart at slike vesentlig forskjellige elektronstrukturer vil ha en meget markert innvirkning på forbindelsene når de utsettes for klorsulfonsyre og medføre at sluttresultatet i realiteten ikke kan forutsies. ^It will be clear that such significantly different electron structures will have a very marked effect on the compounds when they are exposed to chlorosulfonic acid and mean that the end result cannot in reality be predicted. ^
Ved å sammenligne fremgangsmåtene illustrert i de foregående prosesskjemaer, vil det sees at fremgangsmåtene ifølge oppfinnelsen, gående ut fra den lett tilgjengelige og kommersielt erholdbare 2-methoxy- eller 2-hydroxy-benzoesyre, innbefatter bare 3 eller By comparing the methods illustrated in the preceding process diagrams, it will be seen that the methods according to the invention, starting from the easily accessible and commercially obtainable 2-methoxy- or 2-hydroxy-benzoic acid, include only 3 or
4 prosesstrinn, hvilket er 4 eller 5 færre trinn enn i fremgangsmåten ifølge teknikkens stand som går ut fra et like tilgjengelig utgangs-materiale, anisol. Fordelene i form av prosessøkonomi og samlet be-kvemhet son skyldes denne drastiske reduksjon i f remgangsmåtetrinn fra 8 i teknikkens stand til 3 eller 4 ved oppfinnelsen, vil være helt åpenbare. Disse fremgangsmåtefordeler stammer direkte fra den idé å innføre 5-klorsulfonylgruppen i en forutdannet heterocyclisk benz-amidf orbindelse og således unngå de trettende og ubekvemme substitu-sjoner ved oppbygningen av benzoesyre-enheten. Dessuten gir de tre fremgangsmåt et rinn ifølge oppfinnelsen utmerkede totalutbytter, av størrelsesorden JO - 80%, av sulpirid (med høy renhet) i motsetning til utbyttene ved den tidligere kjente fremgangsmåte, som, som vist ved data anført i de tidligere publikasjoner, ikke overstiger 14% 4 process steps, which is 4 or 5 fewer steps than in the method according to the state of the art, which starts from an equally available starting material, anisole. The advantages in terms of process economy and overall convenience due to this drastic reduction in process steps from 8 in the state of the art to 3 or 4 in the case of the invention will be completely obvious. These process advantages derive directly from the idea of introducing the 5-chlorosulfonyl group into a preformed heterocyclic benzamide compound and thus avoiding the thirteenth and inconvenient substitutions in the construction of the benzoic acid unit. In addition, the three methods according to the invention provide excellent overall yields, of the order of JO - 80%, of sulpiride (with high purity) in contrast to the yields of the previously known method, which, as shown by data given in the previous publications, do not exceed 14%
(i fransk patentskrift 1.524-388 er utbyttet opptil slutten av (in French patent document 1,524-388 the yield is up to the end of
trinn 6, dvs. den forutdannede 2-methoxy-5-sulfamoyl-benzoesyre, bare 13 ,5%) . step 6, i.e. the preformed 2-methoxy-5-sulfamoyl-benzoic acid, only 13.5%).
Oppfinnelsens natur vil forståes klarere av de følgende eks-empler . The nature of the invention will be understood more clearly from the following examples.
Eksempel 1 Example 1
1- et hyl- 2-( 2- methoxy- 5- sulfamoylbenzamidomethyl)- pyrrolidin 1- a hyl- 2-( 2- methoxy- 5- sulfamoylbenzamidomethyl)- pyrrolidine
4,8 g (0,016 mol) 1-ethyl-2-(2-methoxybenzamidomethyl)-pyrrolidin -hydroklorid ble tilsatt i små porsjpner til 46,6 g (0,40 mol) klorsulfonsyre avkjølt til O - 5°C. Blandingen ble så oppvarmet ved 75°C i 6 timer, avkjølt til 30°C og derpå helt i en blanding av 6o g knust is og 40 g konsentrert ammoniumhydroxyd (som kilde til ammoniakk). Den dannede oppløsning ble omrørt ved 0 - 5°C i 6 timer, hvorefter de faste stoffer ble frafiltrert, tørret ved 60°C, hvorved man fikk 5,0 g (utbytte: 92%) av en gråhvitt, fast stoff. 4.8 g (0.016 mol) of 1-ethyl-2-(2-methoxybenzamidomethyl)-pyrrolidine hydrochloride was added in small portions to 46.6 g (0.40 mol) of chlorosulfonic acid cooled to 0-5°C. The mixture was then heated at 75°C for 6 hours, cooled to 30°C and then poured into a mixture of 60 g of crushed ice and 40 g of concentrated ammonium hydroxide (as a source of ammonia). The resulting solution was stirred at 0 - 5°C for 6 hours, after which the solids were filtered off, dried at 60°C, whereby 5.0 g (yield: 92%) of a grey-white solid was obtained.
En prøve av den frie base ble overført til hydrokloridsaltet og en analyseprøve omkrystallisert fra methanol. A sample of the free base was transferred to the hydrochloride salt and an analytical sample recrystallized from methanol.
Smeltepunkt: 233 - 234°C. Melting point: 233 - 234°C.
Elementæranalyse: Elemental analysis:
Eksempel 2 Example 2
1- ethy1- 2-( 2- methoxy- 5- sulfamoylbenzamidomethyl)- pyrrolidin 1- ethy1- 2-( 2- methoxy- 5- sulfamoylbenzamidomethyl)- pyrrolidine
En oppløsning av 7,9 g (0,03 mol) l-ethyl-2-(2-methoxybenzamido-methyl)-pyrrolidin i 18 ml methylenklorid ble syret (pH 1) med hydro-genkloridgass, og oppløsningen ble så tilsatt til 87>49 (0,75 mol) klorsulfonsyre. Den dannede oppløsning ble oppvarmet ved 75°C i 6 timer, idet methylenkloridet ble avdestillert i løpet av denne tid. Den avkjølte blanding ble langsomt helt i knust is/ammoniumhydroxyd, idet der hele tiden ble opprettholdt en basisk pH. Den erholdte suspensjon ble ekstrahert med kloroform, ekstraktene ble vasket iut.J. vann, tørret over natriumsulfat og kloroformen avdestillert, hvorved man fikk det ønskede produkt i godt utbytte. En analyseprøve ble omkrystallis ert fra kloroform. A solution of 7.9 g (0.03 mol) of 1-ethyl-2-(2-methoxybenzamido-methyl)-pyrrolidine in 18 ml of methylene chloride was acidified (pH 1) with hydrogen chloride gas, and the solution was then added to 87 >49 (0.75 mol) chlorosulfonic acid. The resulting solution was heated at 75°C for 6 hours, during which time the methylene chloride was distilled off. The cooled mixture was slowly poured into crushed ice/ammonium hydroxide, maintaining a basic pH throughout. The suspension obtained was extracted with chloroform, the extracts were washed out.J. water, dried over sodium sulfate and the chloroform distilled off, whereby the desired product was obtained in good yield. An analytical sample was recrystallized from chloroform.
Smeltepunkt: 177 - 179°C Melting point: 177 - 179°C
En prøve ble overført til hydrokloridsaltet ved behandling med hydrogenklorid i ethanol og omkrystallisert for analyse fra methanol. A sample was transferred to the hydrochloride salt by treatment with hydrogen chloride in ethanol and recrystallized for analysis from methanol.
Smeltepunkt: 233 - 234° C Melting point: 233 - 234° C
Eleme ntæranalyse: Element proximate analysis:
l-ethyl-2-(2-methoxybenzamidomethyl)-pyrrolidin-utgangsmat eria le ble fremstilt ved en av de følgende metoder: 1-ethyl-2-(2-methoxybenzamidomethyl)-pyrrolidine starting material was prepared by one of the following methods:
Metode A Method A
2,27 g (0,011 mol) N,N'-dicyclohexylcarbodiimid ble tilsatt til en oppløsning av 1,52 g (0,01 mol) 2-methoxy-benzoesyre og 1,28 g (0,01 mol) l-methyl-2-aminoethyl-pyrrolidin i lo ml acetonitril. Den erholdte oppløsning ble omrørt ved værelsetemperatur i 4 timer. Det utfelte N,N<*->dicyclohexylurea ble frafiltrert, og morlutene inn- 2.27 g (0.011 mol) of N,N'-dicyclohexylcarbodiimide was added to a solution of 1.52 g (0.01 mol) of 2-methoxy-benzoic acid and 1.28 g (0.01 mol) of l-methyl- 2-aminoethyl-pyrrolidine in 10 ml acetonitrile. The resulting solution was stirred at room temperature for 4 hours. The precipitated N,N<*->dicyclohexylurea was filtered off, and the mother liquors in-
dampet til tørrhet. Residuet ble oppløst i kloroform, oppløsningen ble vasket godt med vann og kloroformen tørret og fordampet, hvorved man fikk 2,34 g (utbytte 90%) av det ønskede produkt i form av en beige olje. Dette produkt ble vist å være identisk med en autentisk prøve ved tynn-skiktskromatografi og sammenligning-av infrarøde oppløsningsspektra. Eksempel 5 l- ethyl- 2-( 2- methoxybenzylamidomethyl)- pyrrolidin steamed to dryness. The residue was dissolved in chloroform, the solution was washed well with water and the chloroform dried and evaporated, whereby 2.34 g (yield 90%) of the desired product was obtained in the form of a beige oil. This product was shown to be identical to an authentic sample by thin layer chromatography and comparison of infrared resolution spectra. Example 5 1-ethyl-2-(2-methoxybenzylamidomethyl)-pyrrolidine
2,8 9 (0,0165 mol) siliciumtetraklorid ble tilsatt langsomt til en godt omrørt oppløsning av 6 g (0,0396 mol) 2-methoxybenzoesyre, 2.8 9 (0.0165 mol) silicon tetrachloride was added slowly to a well-stirred solution of 6 g (0.0396 mol) 2-methoxybenzoic acid,
6,7 g (0,066 mol) triethylamin og 4,22 g (0,033 mol) N-ethyl-2-amino-ethylpyrrolidin i 225 ml toluen. Den dannede blanding ble kokt under til-bakeløp i 3 timer hvorefter de utfolte faste stoffer ble frafiltrert og vasket med toluen. Det forenede toluenfiltrat og vaskinger ble vasket med 100 ml 2%- lg vandig natriumhydroxydoppløsning, 100 ml vann, tørret og toluenet avdestillert under nedsatt trykk, hvilket ga 7,9 g (utbytte: 91%) av det ønskede produkt som en beige olje. En prøve ble over-ført til hydrokloridsaltet ved behandling med hydrogenklorid i methyl-ethylketon og omkrystallisert for analyse fra det samme oppiøsningsmiddeL Smeltepunkt: 174 - 176°C. 6.7 g (0.066 mol) of triethylamine and 4.22 g (0.033 mol) of N-ethyl-2-amino-ethylpyrrolidine in 225 ml of toluene. The resulting mixture was refluxed for 3 hours, after which the precipitated solids were filtered off and washed with toluene. The combined toluene filtrate and washings were washed with 100 ml of 2% wt aqueous sodium hydroxide solution, 100 ml of water, dried and the toluene distilled off under reduced pressure to give 7.9 g (yield: 91%) of the desired product as a beige oil. A sample was converted to the hydrochloride salt by treatment with hydrogen chloride in methyl ethyl ketone and recrystallized for analysis from the same solvent. Melting point: 174 - 176°C.
Elementæranalyse: Elemental analysis:
Metode C Method C
Del ( a) Part (a)
1- ethyl- 2-( 2- hydroxybenzamidomethyl)- pyrrolidin 1-ethyl-2-(2-hydroxybenzamidomethyl)-pyrrolidine
25 g (0,21 mol) thionylklorid ble tilsatt til en suspensjon av 28 g (0,203 mol) salicylsyre i 150 ml petrolether (30 - 60°C) inneholdende 0,1 g pyridin. Blandingen ble oppvarmet ved 40°C i 2,5 timer, av-kjølt til værelsetemperatur, filtrert og oppløsningsmidlet avdestillert, hvorved man fikk produktet som en blek, gul olje som ble renset ved destillasjon, hvilket ga en farveløs olje i godt utbytte. 25 g (0.21 mol) of thionyl chloride was added to a suspension of 28 g (0.203 mol) of salicylic acid in 150 ml of petroleum ether (30-60°C) containing 0.1 g of pyridine. The mixture was heated at 40°C for 2.5 hours, cooled to room temperature, filtered and the solvent distilled off to give the product as a pale yellow oil which was purified by distillation to give a colorless oil in good yield.
Kokepunkt 55 - 6o°C/l mm Hg. Boiling point 55 - 6o°C/l mm Hg.
En oppløsning av 6,2 g (0,039 mol) salicylylklorid i 33 ml kloroform ble tilsatt langsomt ved 0 - 5°C til en oppløsning av 5 g (0,039 mol) l-ethyl-2-aminomethyl-pyrrolidin i 5 ml kloroform. Den dannede oppløsning ble omrørt ved værelsetemperatur i 30 minutter og derpå gjort alkalisk (pH 10 - 11) med konsentrert ammoniumhydroxyd/ vann. Det organiske skikt ble vasket med vann, tørret over natriumsulfat og kloroformen avdestillert, hvorved man fikk produktet som en beige olje i kvantitativt (100%) utbytte. A solution of 6.2 g (0.039 mol) of salicylyl chloride in 33 ml of chloroform was added slowly at 0-5°C to a solution of 5 g (0.039 mol) of 1-ethyl-2-aminomethyl-pyrrolidine in 5 ml of chloroform. The resulting solution was stirred at room temperature for 30 minutes and then made alkaline (pH 10 - 11) with concentrated ammonium hydroxide/water. The organic layer was washed with water, dried over sodium sulfate and the chloroform distilled off, whereby the product was obtained as a beige oil in quantitative (100%) yield.
Del ( b) Part (b)
1- ethyl- 2-( 2- met hoxybenzamidomethyl)- pyrrolidin 1- ethyl- 2-( 2- met hoxybenzamidomethyl)- pyrrolidine
5,5 g (0,044 mol) dimethylsulfat ble tilsatt langsomt ved værelsetemperatur til en suspensjon av 9,7 9 l-ethyl-2-(2-hydroxybenz-amidomethyl)-pyrrolidin erholdt ved fremgangsmåten i del (a) og 10,9 g (0,078 mol) vannfritt kaliumcarbonat i 100 ml aceton. Blandingen ble kokt under tilbakeløp i 18 timer og acetonet avdestillert så fullstendig som mulig. Residuet ble fordelt mellom methylenklorid og vann, den organiske fase ble fraskilt, vasket med vann og tørret over natriumsulfat . Methylenkloridet ble avdestillert, hvorved man fikk produktet som en blek, gul olje, (utbytte: 78%)- 5.5 g (0.044 mol) of dimethyl sulfate was added slowly at room temperature to a suspension of 9.7 9 l-ethyl-2-(2-hydroxybenz-amidomethyl)-pyrrolidine obtained by the procedure in part (a) and 10.9 g (0.078 mol) of anhydrous potassium carbonate in 100 ml of acetone. The mixture was refluxed for 18 hours and the acetone distilled off as completely as possible. The residue was partitioned between methylene chloride and water, the organic phase was separated, washed with water and dried over sodium sulfate. The methylene chloride was distilled off, whereby the product was obtained as a pale, yellow oil, (yield: 78%)-
En prøve ble overført til hydrokloridsaltet ved behandling med hydrogenklorid i methanol og krystallisert for analyse, fra methyl <^thyl-ket on. A sample was converted to the hydrochloride salt by treatment with hydrogen chloride in methanol and crystallized for analysis from methyl ethyl ketone.
Smeltepunkt: 176 - 179°C. Melting point: 176 - 179°C.
Elementæranalyse: Elemental analysis:
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26580372A | 1972-06-23 | 1972-06-23 | |
GB5624072 | 1972-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO142301B true NO142301B (en) | 1980-04-21 |
Family
ID=26267599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO259273A NO142301B (en) | 1972-06-23 | 1973-06-22 | PROCEDURE FOR THE PREPARATION OF HETEROCYCLIC BENZAMIDE COMPOUNDS |
Country Status (11)
Country | Link |
---|---|
AR (1) | AR211685A1 (en) |
CA (1) | CA982589A (en) |
CH (1) | CH584688A5 (en) |
DE (1) | DE2331959A1 (en) |
DK (1) | DK136359B (en) |
ES (1) | ES416231A1 (en) |
FI (1) | FI59794C (en) |
FR (1) | FR2189062A1 (en) |
NL (1) | NL7308729A (en) |
NO (1) | NO142301B (en) |
SE (1) | SE389107B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2445829A2 (en) * | 1978-02-27 | 1980-08-01 | Synthelabo | METHOXY-2 BENZAMIDES AND THEIR THERAPEUTIC APPLICATION |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3342826A (en) * | 1964-01-13 | 1967-09-19 | Ile De France | Heterocyclic aminoalkyl benzamides |
ES403003A1 (en) * | 1972-05-19 | 1973-06-16 | Lepori Renault | Method of preparing 2-methoxy-n-n-ethylpyrrolidin-2-yl- methyl-5-sulphamoyl-benzamide |
-
1973
- 1973-06-18 CH CH898773A patent/CH584688A5/xx not_active IP Right Cessation
- 1973-06-19 SE SE7308591A patent/SE389107B/en unknown
- 1973-06-20 FR FR7322534A patent/FR2189062A1/en active Granted
- 1973-06-20 FI FI199873A patent/FI59794C/en active
- 1973-06-21 DK DK343973A patent/DK136359B/en unknown
- 1973-06-22 AR AR24866373A patent/AR211685A1/en active
- 1973-06-22 DE DE19732331959 patent/DE2331959A1/en active Pending
- 1973-06-22 CA CA174,723A patent/CA982589A/en not_active Expired
- 1973-06-22 NL NL7308729A patent/NL7308729A/xx not_active Application Discontinuation
- 1973-06-22 NO NO259273A patent/NO142301B/en unknown
-
1975
- 1975-09-18 ES ES416231A patent/ES416231A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE2331959A1 (en) | 1974-01-10 |
FR2189062A1 (en) | 1974-01-25 |
ES416231A1 (en) | 1976-05-01 |
SE389107B (en) | 1976-10-25 |
FI59794B (en) | 1981-06-30 |
CA982589A (en) | 1976-01-27 |
DK136359B (en) | 1977-10-03 |
FI59794C (en) | 1981-10-12 |
AR211685A1 (en) | 1978-02-28 |
CH584688A5 (en) | 1977-02-15 |
NL7308729A (en) | 1973-12-27 |
FR2189062B1 (en) | 1976-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | An improved method of amide synthesis using acyl chlorides | |
JP2005511782A (en) | Process for the preparation of 2-halogenacyl-3-amino-acrylic acid derivatives | |
NO170847B (en) | PROCEDURE FOR PREPARING 1 ADAMANTAN DERIVATIVES | |
AT262274B (en) | Process for the production of new indole derivatives | |
ES2370830T3 (en) | PROCEDURE FOR THE PRODUCTION OF (Z) -1-PHENYL-1-DIETHYLAMINOCARBONYL-2-AMINOMETIL CYCLOPROPAN CHLORHYDRATE | |
SU578870A3 (en) | Method of preparing n-(methoxymethyl)furilmethyl-6,7-benzomorphanes or morhinanes or their salts | |
US4350635A (en) | N(2-Pyrrolidinylmethyl)meta-sulfonamido-benzamides | |
NO121950B (en) | ||
Okuda et al. | Polycyclic N-heterocyclic compounds. Part 61: A novel Truce–Smiles type rearrangement reaction of 4-(2-cyanovinyloxy) butanenitriles to give cycloalkeno [1, 2-d] furo [2, 3-b] pyridines | |
NO142301B (en) | PROCEDURE FOR THE PREPARATION OF HETEROCYCLIC BENZAMIDE COMPOUNDS | |
CN112574087B (en) | Synthetic method of 3-aminopyrrolidine hydrochloride | |
Jiang et al. | Reactions of methylenecyclopropanes and vinylidenecyclopropanes with N-fluorodibenzenesulfonimide | |
CN107935909B (en) | Synthesis method of nintedanib and intermediate thereof | |
DK152752B (en) | METHOD OF PREPARING L-SULPIRIDE | |
Ma et al. | Pd/Cu-catalyzed couplings of β-amino esters with aryl bromides. Synthesis of chiral 1, 2, 3, 4-tetrahydro-4-oxo-2-alkyl-1-quinolines | |
SU448644A3 (en) | The method of obtaining isoindoline derivatives | |
KR20020052213A (en) | Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo[1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates | |
CH574921A5 (en) | Anti-inflammatory alpha-aminophenyl carboxylic acids | |
NO152818B (en) | DEVICE (TERMINATION) OF CANON CABLE | |
NO142300B (en) | Heterocyclic benzamide compounds for use as intermediate in the preparation of a pharmacologically active hetero-cyclic benzamide | |
NO812871L (en) | PROCEDURE FOR PREPARATION OF N-SUBSTITUTED N-PYRROLIDINES | |
CN102482214A (en) | Intermediates and processes for preparing 4- (acetylamino) -3- [ (4-chloro-phenyl) thio ] -2-methyl-1H-indole-1-acetic acid | |
NO822471L (en) | PROCEDURE FOR PREPARING SUBSTITUTED PYROLS | |
NO136460B (en) | ||
NO165419B (en) | DEVICE FOR LOADING AND RELEASE OF GOODS INTENDED FOR PUBLIC USE, SUCH AS BAGGAGE TRUCKS. |